Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Abroad (travel likely)RecruitingPHASE2
Conditions
Migraine
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sunwise Clinical Research, Llc, Walnut Creek, California, United States
Clinical Neuroscineces Solutions - Orlando, Orlando, Florida, United States
Clinical Neuroscineces Solutions, Orlando, Florida, United States
M3 Wake Research - Las Vegas Rainbow, Las Vegas, Nevada, United States
Clinical Research Associates, Inc., Nashville, Tennessee, United States
Highland Research, Salt Lake City, Utah, United States